首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1746598

日本藥物篩選市場報告（按產品和服務、樣本類型、最終用戶和地區分類）2025 年至 2033 年

Japan Drug Screening Market Report by Product and Service, Sample Type, End User, and Region 2025-2033

出版日期: 2025年06月02日 | 出版商:

IMARC | 英文 119 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2024年，日本藥物篩檢市場規模達4.063億美元。展望未來， IMARC Group預計到2033年，該市場規模將達到13.533億美元，2025-2033年期間的複合年成長率（CAGR）為14.3%。推動該市場發展的幾個重要因素包括毒販和本地毒販的日益增多、藥物濫用案件的激增以及虛擬貨幣的使用日益增多。

藥物篩檢涉及採集和檢查個別血液、尿液、頭髮或唾液，以識別其中是否存在提示藥物使用的物質和化學物質。該過程涵蓋多種檢測方法，包括酶聯免疫吸附測定 (IAs)、氣相層析 (GC) 和液相層析/質譜 (LC/MS)。當初步結果呈陽性時，LC/MS 被認為是一種高效且高精度的確認方法。其主要目的是檢測藥物的合法和非法使用，涵蓋可卡因、海洛因和 3,4-亞甲基二氧基甲基安非他命 (MDMA) 等非法物質。此外，它還用於識別各種處方藥的濫用情況，例如藥物濫用或過量使用。藥物篩檢在臨床試驗中對評估新藥的有效性和安全性起著至關重要的作用。此外，它也是法律訴訟的重要組成部分，服務於刑事執法目的。此外，它還有助於評估接受鴉片類藥物治療的患者濫用藥物的可能性和依從性。

日本藥物篩選市場趨勢：

日本藥物篩檢市場目前正經歷顯著成長，這受到多種因素的推動。其中最重要的因素是藥物篩檢需求的不斷成長，這得益於其準確性和快速交付結果的優勢，使其成為各種應用的理想選擇。此外，隨著社會努力應對成癮及其後果的挑戰，藥物濫用案件的增加是市場擴張的關鍵驅動力。另一個促進市場成長的因素是，越來越多人將藥物視為應對壓力、焦慮和生活困境的機制，進一步凸顯了有效的藥物篩檢的重要性。此外，政府機構也發揮關鍵作用，他們啟動定期路邊唾液篩檢，以檢測吸毒駕駛員，並啟動藥物濫用和成癮項目，以滿足吸毒者的需求。此外，由於虛擬貨幣為買賣雙方提供了匿名性，毒販和當地經銷商的存在也推動了市場的擴張。這些因素將共同促成日本藥物篩檢市場在預測期內的樂觀前景。

日本藥物篩選市場細分：

產品和服務洞察：

裝置
- 免疫分析儀
- 色譜儀器
- 呼吸分析儀
快速檢測設備
- 尿液檢測設備
- 口腔液體檢測設備
耗材
- 檢測試劑盒
- 樣品收集杯
- 校準器和控制器
- 其他
實驗室服務

樣本類型洞察：

尿液樣本
呼吸樣本
口腔液體樣本
頭髮樣本
其他

最終用戶洞察：

醫院
藥物檢測實驗室
工作場所
藥物治療中心
疼痛管理中心
個人用戶
刑事司法系統和執法機構

競爭格局：

市場研究報告也對市場競爭格局進行了全面分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭指標和公司評估象限等競爭分析。此外，報告還提供了所有主要公司的詳細資料。

本報告回答的關鍵問題：

日本藥物篩選市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本藥物篩選市場有何影響？
日本藥物篩選市場依產品和服務的分類是怎樣的？
根據樣本類型，日本藥物篩選市場是如何分類的？
根據最終用戶，日本藥物篩選市場是如何分類的？
日本藥物篩選市場的價值鏈分為哪些階段？
日本藥物篩選的關鍵促進因素和挑戰是什麼？
日本藥物篩選市場的結構是怎麼樣的？主要參與者是誰？
日本藥物篩選市場的競爭程度如何？

本報告回答的關鍵問題：

日本藥物篩選市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本藥物篩選市場有何影響？
日本藥物篩選市場依產品和服務的分類是怎樣的？
根據樣本類型，日本藥物篩選市場是如何分類的？
根據最終用戶，日本藥物篩選市場是如何分類的？
日本藥物篩選市場的價值鏈分為哪些階段？
日本藥物篩選的關鍵促進因素和挑戰是什麼？
日本藥物篩選市場的結構是怎麼樣的？主要參與者是誰？
日本藥物篩選市場的競爭程度如何？

裝置
- 概述
- 市場區隔
  - 免疫分析儀
  - 色譜儀器
  - 呼吸分析儀
快速檢測設備
- 概述
- 市場區隔
  - 尿液檢測設備
  - 口腔液體檢測設備
耗材
- 概述
- 市場區隔
  - 檢測試劑盒
  - 樣品收集杯
  - 校準器和控制器
  - 其他
實驗室服務
- 概述

第7章：日本藥物篩選市場-細分：依樣本類型

尿液樣本
- 概述
呼吸樣本
- 概述
口腔液體樣本
- 概述
頭髮樣本
- 概述
其他

第 8 章：日本藥物篩選市場 - 細分：按最終用戶

醫院
- 概述
藥物檢測實驗室
- 概述
工作場所
- 概述
藥物治療中心
- 概述
疼痛管理中心
- 概述
個人用戶
- 概述
刑事司法系統和執法機構
- 概述

第9章：日本藥物篩選市場－競爭格局

概述
市場結構
市場參與者定位
最佳獲勝策略
競爭儀錶板
公司評估象限

第10章：關鍵參與者簡介

Company A

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company B

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company C

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company D

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company E

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

第 11 章：日本藥物篩選市場 - 產業分析

促進因素、限制因素和機遇
- 概述
- 驅動程式
- 限制
- 機會
波特五力分析
- 概述
- 買家的議價能力
- 供應商的議價能力
- 競爭程度
- 新進入者的威脅
- 替代品的威脅
價值鏈分析

第 12 章：附錄

簡介目錄

Product Code: SR112025A19553

Japan drug screening market size reached USD 406.3 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,353.3 Million by 2033, exhibiting a growth rate (CAGR) of 14.3% during 2025-2033. The market is being propelled by several significant factors, including the escalating presence of drug traffickers and local dealers, a surge in substance abuse cases, and the growing utilization of virtual currencies.

Drug screening involves the procedure of collecting and examining an individual's blood, urine, hair, or saliva to identify the presence of substances and chemicals indicative of drug use. This process encompasses a wide array of testing methods, including enzyme immunoassays (IAs), gas chromatography (GC), and liquid chromatography/mass spectrometry (LC/MS), which is considered a superior and highly precise confirmation test utilized when initial results show positive. Its primary purpose is to detect both the legitimate and illegitimate use of drugs, spanning illegal substances like cocaine, heroin, and 3,4-Methylenedioxymethamphetamine (MDMA). Additionally, it is employed to identify the misuse of various prescription medications when they are consumed differently or in excessive quantities. Drug screening plays a crucial role in clinical trials for evaluating the effectiveness and safety of novel drugs. Moreover, it is an essential component in legal proceedings, serving the purposes of criminal law enforcement. Furthermore, it aids in assessing the potential for abuse and adherence among patients receiving opioid therapy.

Japan Drug Screening Market Trends:

The Japan drug screening market is currently experiencing significant growth driven by a multitude of influential factors. Foremost among these factors is the rising demand for drug screening due to its accuracy and the rapid delivery of results, making it an appealing choice for various applications. Moreover, the increase in cases of substance abuse is a key driver of market expansion, as societies grapple with the challenges of addiction and its consequences. Another factor contributing to the market's growth is the growing prevalence of drug use as a coping mechanism for stress, anxiety, and life's hardships, further emphasizing the need for effective drug screening. Additionally, government agencies are also playing a pivotal role by initiating regular roadside oral fluid screening to detect drug-impaired drivers and launching substance abuse and addiction programs to address the needs of addicts. Furthermore, the presence of drug traffickers and local dealers, facilitated by the use of virtual currencies that offer anonymity to buyers and sellers, is supporting the market's expansion. These factors will collectively contribute to the positive outlook for the drug screening market in Japan over the forecasted period.

Japan Drug Screening Market Segmentation:

Product and Service Insights:

Equipment
- Immunoassay Analyzers
- Chromatography Instruments
- Breath Analyzers
Rapid Testing Devices
- Urine Testing Devices
- Oral Fluid Testing Devices
Consumables
- Assay Kits
- Sample Collection Cups
- Calibrators and Controls
- Others
Laboratory Services

Sample Type Insights:

Urine Samples
Breath Samples
Oral Fluid Samples
Hair Samples
Others

End User Insights:

Hospitals
Drug Testing Laboratories
Workplaces
Drug Treatment Centers
Pain Management Centers
Personal Users
Criminal Justice System and Law Enforcement Agencies

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan drug screening market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan drug screening market?
What is the breakup of the Japan drug screening market on the basis of product and service?
What is the breakup of the Japan drug screening market on the basis of sample type?
What is the breakup of the Japan drug screening market on the basis of end user?
What are the various stages in the value chain of the Japan drug screening market?
What are the key driving factors and challenges in the Japan drug screening?
What is the structure of the Japan drug screening market and who are the key players?
What is the degree of competition in the Japan drug screening market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Drug Screening Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Drug Screening Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Drug Screening Market - Breakup by Product and Service

6.1 Equipment
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Segmentation
  - 6.1.3.1 Immunoassay Analyzers
  - 6.1.3.2 Chromatography Instruments
  - 6.1.3.3 Breath Analyzers
- 6.1.4 Market Forecast (2025-2033)
6.2 Rapid Testing Devices
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Segmentation
  - 6.2.3.1 Urine Testing Devices
  - 6.2.3.2 Oral Fluid Testing Devices
- 6.2.4 Market Forecast (2025-2033)
6.3 Consumables
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2019-2024)
- 6.3.3 Market Segmentation
  - 6.3.3.1 Assay Kits
  - 6.3.3.2 Sample Collection Cups
  - 6.3.3.3 Calibrators and Controls
  - 6.3.3.4 Others
- 6.3.4 Market Forecast (2025-2033)
6.4 Laboratory Services
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2019-2024)
- 6.4.3 Market Forecast (2025-2033)

7 Japan Drug Screening Market - Breakup by Sample Type

7.1 Urine Samples
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 Breath Samples
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
7.3 Oral Fluid Samples
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)
7.4 Hair Samples
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2019-2024)
- 7.4.3 Market Forecast (2025-2033)
7.5 Others
- 7.5.1 Historical and Current Market Trends (2019-2024)
- 7.5.2 Market Forecast (2025-2033)

8 Japan Drug Screening Market - Breakup by End User

8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Drug Testing Laboratories
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
8.3 Workplaces
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)
8.4 Drug Treatment Centers
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2019-2024)
- 8.4.3 Market Forecast (2025-2033)
8.5 Pain Management Centers
- 8.5.1 Overview
- 8.5.2 Historical and Current Market Trends (2019-2024)
- 8.5.3 Market Forecast (2025-2033)
8.6 Personal Users
- 8.6.1 Overview
- 8.6.2 Historical and Current Market Trends (2019-2024)
- 8.6.3 Market Forecast (2025-2033)
8.7 Criminal Justice System and Law Enforcement Agencies
- 8.7.1 Overview
- 8.7.2 Historical and Current Market Trends (2019-2024)
- 8.7.3 Market Forecast (2025-2033)

9 Japan Drug Screening Market - Competitive Landscape

9.1 Overview
9.2 Market Structure
9.3 Market Player Positioning
9.4 Top Winning Strategies
9.5 Competitive Dashboard
9.6 Company Evaluation Quadrant

10 Profiles of Key Players

10.1 Company A
- 10.1.1 Business Overview
- 10.1.2 Product Portfolio
- 10.1.3 Business Strategies
- 10.1.4 SWOT Analysis
- 10.1.5 Major News and Events
10.2 Company B
- 10.2.1 Business Overview
- 10.2.2 Product Portfolio
- 10.2.3 Business Strategies
- 10.2.4 SWOT Analysis
- 10.2.5 Major News and Events
10.3 Company C
- 10.3.1 Business Overview
- 10.3.2 Product Portfolio
- 10.3.3 Business Strategies
- 10.3.4 SWOT Analysis
- 10.3.5 Major News and Events
10.4 Company D
- 10.4.1 Business Overview
- 10.4.2 Product Portfolio
- 10.4.3 Business Strategies
- 10.4.4 SWOT Analysis
- 10.4.5 Major News and Events
10.5 Company E
- 10.5.1 Business Overview
- 10.5.2 Product Portfolio
- 10.5.3 Business Strategies
- 10.5.4 SWOT Analysis
- 10.5.5 Major News and Events

11 Japan Drug Screening Market - Industry Analysis

11.1 Drivers, Restraints, and Opportunities
- 11.1.1 Overview
- 11.1.2 Drivers
- 11.1.3 Restraints
- 11.1.4 Opportunities
11.2 Porters Five Forces Analysis
- 11.2.1 Overview
- 11.2.2 Bargaining Power of Buyers
- 11.2.3 Bargaining Power of Suppliers
- 11.2.4 Degree of Competition
- 11.2.5 Threat of New Entrants
- 11.2.6 Threat of Substitutes
11.3 Value Chain Analysis